Health Condition 1: K806- Calculus of gallbladder and bile duct with cholecystitis
Conditions
Interventions
Intervention1: laparoscopic cholecystectomy.
Bupivacaine0.25%: Group A-patients will recieve port site infiltration[local] of 20ml of 0.25% Inj Bupivacaine with 4 mg Inj Dexamethasone.
Group B- patien
Sponsors
DR RANJINI SHOME
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA grades 1 and 2 of either sex. 2.Patients between age group of 20 to 60 years. 3.Undergoing elective laparoscopic cholecystectomy under General anesthesia.
Exclusion criteria
Exclusion criteria: 1. Patients with acute cholecystitis. 2. Patients allergic to drug used in the study. 3. Patients who have morbid obesity, choledocholithiasis, patients with chronic pain syndrome, previous upper abdominal surgery, chronic medical disease, chronic opiod treatment. 4. Patients requiring placement of drain postoperatively. 5 Those with stone spillage. 6.Patients in whom conversion to open cholecystectomy was done for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To compare the analgesic efficacy of periportal and intraperitoneal infiltration of 0.25% Bupivacaine with Dexamethasone 4mg using visual analog scale. 2. to compare total analgesic consumption in first 24 hours. 3.To compare the incidence of adverse effects like shoulder pain , vomiting. 4.To compare degree of ambulation in postoperative periodTimepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare the incidence of adverse effects like shoulder tip pain, vomiting. To compare the degree of ambulation. To compare the total analgesic comsumption in first 24 hours.Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr Ranjini Shome
MGR UNIVERSITY
Outcome results
None listed